Sat, Dec 20, 2014, 12:59 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

  • keep_investing keep_investing Jul 27, 2012 7:37 AM Flag

    DR. Lanza acquired more shares

    He acquired 1,285,714 shares on 6/29/2012 at a share price value of $0.062 per share. He now own's a total of 28,529,003 shares.
    Insiders have acquired a ton of shares in June, none sold, so I'm taking this as a positive sign that these guys know what lays ahead, and we'll soon learn what it is, too.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • SEC FORM 8-K
      17-Aug-2011



      Amended and Restated Employment Agreement between the Company and Robert Lanza

      Effective July 1, 2011, the Company entered into an amended and restated employment agreement with Robert Lanza (the “Lanza Agreement”), the Company’s chief scientific officer since October 2007. Pursuant to the Lanza Agreement, the parties agreed as follows:

      Dr. Lanza will continue serve as the Company’s chief scientific officer for a term commencing on July 1, 2011 until September 30, 2013 (subject to earlier termination as provided therein, and extension by mutual written agreement).

      The Company will pay Dr. Lanza a base salary of $440,000 per year, which amount shall increase at the end of each year of the Lanza Agreement, by an amount determined by the board, but by not less than 5% per year. The Company may also pay Dr. Lanza annual bonuses in in the Company’s sole discretion.

      The Company agreed to issue to Dr. Lanza, upon execution of the Lanza Agreement, (i) 15,000,000 shares of common stock (of which 6,000,000 shares will vest on the date of grant, with the balance of 9,000,000 shares vesting in equal installments on the last day of each month commencing on January 31, 2012 and ending on September 30, 2013), (ii) an option to purchase 15,000,000 shares of common stock with an exercise price equal to the closing price on the date of execution (of which 6,000,000 options will vest on the date of grant, with the balance of 9,000,000 options vesting in equal installments on the last day of each month commencing on January 31, 2012 and ending on September 30, 2013).

    • I hope so Keep

 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST